Proliferation in non-Hodgkin's lymphomas and its prognostic value related to staging parameters

Cellular Oncology

Volumn 26, Issue 1-2, 2004, Pages 63-71

  Lorand Metze, Irene ^a   Gonçalves Pereira, Fernanda ^a   Silva Costa, Flávia Pereira ^a   Metze, Konradin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

AgNORs; Cell proliferation; DNA aneuploidy; Lymphoma; Prognosis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CELL CYCLE S PHASE; CELL KINETICS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BIOPSY, FINE-NEEDLE; CELL NUCLEUS; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SILVER STAINING; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 4243169975     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. F.D. Bernardi, L. Antonangelo, R. Beyruti, T. Takagi, P.H. Saldiva and V.L. Capelozzi, A prognostic model of survival in surgically resected sqamous cell carcinoma of the lung using clinical, pathologic and biologic markers, Mod. Pathol. 10 (1997), 992-1000.
2. A. Böocking, R. Chatelain, W. Auffermann, G.R.F. Krüger, B. Asmus, D. Wohltmann and C. Schuster, DNA-grading of malignant lymphomas. I. Prognostic significance, reproducibility and comparison with other classifications, Anticancer Res. 6 (1986), 1205-1216.
3. A. Böcking, R. Chatelain, W. Auffermann, G.W. Löhr, M. Reif, R. Rossner and H. Becker, DNA-grading of malignant lymphomas. II. Correlation with clinical parameters, Anticancer Res. 6 (1986), 1217-1224.
4. V. Canet, M.P. Montmasson, Y. Usson, F. Giroud and G. Brugal, Correlation between silver-stained nucleolar organizer region area and cell cycle time, Cytometry 43 (2001), 110-116.
5. I.A.M. Gisbertz, H.C. Schouten, F.J. Bot and J.-W. Arends, Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma, Cancer 83 (1999), 158-165.
6. J. Grace, R. Stankovic and L. Gupta, Detection of aneuploidy in non-Hodgkin's lymphoma by computer assisted video image analysis, Analyt. Quant. Cytol. Histol. 15 (1993), 265-273.
7. H.J. Grote, N. Friedrichs, N. Pomjanski, H.F. Guhde, O. Reich and A. Böcking, Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage Ib and II, Analyt. Cell. Pathol. 23 (2001), 97-105.
8. H.Z.M. Grotto, I. Lorand-Metze and K. Metze, Nucleolar organizer regions in normal hematopoiesis. Relationship to cellular proliferation and maturation, Nouv. Rev. Fr. Hematol. 33 (1991), 1-4.
9. L. Gunther, P. Hufnagl, K.J. Winzer and H. Guski, Different proliferation patterns in breast cancer: AgNOR measurements in ER-negative and ER-positive tumour cells, Analyt. Cell. Pathol. 20 (2000), 155-162.
10. N.L. Harris, E.S. Jaffe, J. Diebold et al., The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Comittee Meeting, Airlie House, Virginia, November 1997, Histopathology 36 (2000), 69-87.
11. H. Holte, Z. Suo, E.B. Smeland, S. Kvaloy, R. Langholm and T. Stokke, Prognostic value of lymphoma-specific S-phase fraction compared with that of other proliferation markers, Acta Oncol. 38 (1999), 495-503.
12. P. Korkoropoulou, M.K. Angelopoulou, F. Kontopidou et al., Prognostic implications of PCNA, AgNORs and p53 in non-Hodgkin's lymphomas, Leuk. Lymphoma 30 (1998), 625-636.
13. I.A. Korneyev, N.N. Mamaev, V.V. Kozlov, M.G. Rybakova and S.H. al-Shukri, Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours, Mol. Pathol. 53 (2000), 129-32.
14. I. Lorand-Metze, M.A. Carvalho and K. Metze, Relationship between morphometric analysis of nucleolar organizer regions and cell proliferation in acute leukemias, Cytometry 32 (1998), 51-56.
15. I. Lorand-Metze and K. Metze, AgNOR clusters as a parameter of cell kinetics in chronic lymphacytic leukemia, J. Clin. Pathol.: Mol. Pathol. 49 (1996), M357-M360.
16. A.R. Martin, D. Weisenburger, W.C. Chan et al., Prognostic value of cellular proliferation and histologic grade in follicular lymphoma, Blood 85 (1995), 3671-3678.
17. K. Metze, A.C. Chiari, RL. Andrade and I. Lorand-Metze, Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia, Hematol. Cell. Therap. 41 (1999), 205-210.
18. K. Metze and I. Lorand-Metze, Methods for analysing AgNORs, J. Clin. Pathol. - Mol. Pathol. 52 (1999), 550.
19. K. Metze, A.M. Lobo and I. Lorand-Metze, Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lymphocytic leukemia, Int. J. Cancer (Pred Oncol.) 89 (2000), 440-443.
20. K. Metze, E.M. Cia and M.A. Trevisan, Evaluation of nucleolar organizer regions in human bladder cancers, Eur. Urol. 37 (2000), 118-119.
21. K. Metze, W. Souza Filho, R.A. Adam and I. Lorand-Metze, Analysis of the component "tree" as a new tool for analytical cellular pathology, Anal. Cell. Pathol. 22 (2001), 65.
22. K. Metze, G.B. Oliveira, F.G. Pereira and I. Lorand-Metze, Spontaneous apoptosis in chronic lymphocytic leukemia and its relation to treatment free period, Anal. Cell. Pathol. 25(5) (2003), 269.
23. O. Ng, A comparative study of nucleolar organizer region, proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours, J. Gastroenterol. Hepatol. 13 (1998), 794-800.
24. G.B. Oliveira, RG. Pereira, K. Metze and I. Lorand-Metze, Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters, Cytometry 46 (2001), 329-335.
25. K.B.B. Pagnano, J. Vassallo, I. Lorand-Metze and F.F. Costa, STO Saad. P53, MDM2, and c-Myc overexpression is associated with a poor prognosis in agressive non-Hodgkin's lymphomas, Am. J. Hematol. 67 (2001), 84-92.
26. A. Pich, L. Chiusa, E. Audisio and F. Marmont, Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients, J. Clin. Oncol. 16 (1998), 1512-1518.
27. N. Pomjanski, H. Motherby, B. Buckstegge, K. Knops, B.L. Rohn and A. Böcking, Early diagnosis of mesothelioma in serous effusions using the AgNOR analysis, Anal. Quant. Cytol Histol. 23 (2001), 151-160.
28. R. Raty, K. Fransilla, S.E. Jansson, H. Joensuu, U. Wartiovaara-Kautto and E. Elonen, Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma, Eur. J. Cancer 39 (2003), 321-329.
29. A. Reiter, M. Schrappe, W. Ludwig, W. Hiddemann, S. Sauter, G. Henze, M. Zimmermann, F. Lampert, W. Havers, O.E. Niethammer, J. Ritter, G. Mann, K. Welte, H. Gardner and H. Riehm, Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM'86, Blood 84 (1994), 3122-3133.
30. T.W. Remmerbach, H. Weidenbach, C. Müller, A. Hemprich, N. Pomjanski, B. Buckstegge and A. Böcking, Diagnostic value of nucleolar organizer regions in brush biopsies of suspicious lesions of the oral cavity, Analyt. Cell. Pathol. 25 (2003), 139-146.
31. A. Rosenwald, G. Wright, A. Wienster et al. for the Lymphoma/Leukemia Molecular Profiling Project, The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma, Cancer Cell. 3 (2003), 185-197.
32. U.M. Saikia, P. Dey, H. Vohra and S.K. Gupta, DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse, Diagn. Cytopathol. 22 (2000), 152-156.
33. I. Salmon, F. Swan Jr., J.L. Dargent, J.L. Pasteels, R. Kiss and R.L. Katz, Relationship between DNA ploidy level, nuclear size, and survival in large cell lymphoma, Am. J. Clin. Pathol. 103 (1995), 568-573.
34. M. Sánchez-Beato, A. Sánchez-Aguillera and M.A. Piris, Cell cycle deregulation in B-cell lymphomas, Blood 101 (2003), 1220-1235.
35. M. Stetler-Stevenson and R. Braylan, Flow cytometric analysis of lymphomas and lymphoprpliferative disorders. Semin. Hematol. 38 (2001), 111-123.
36. G. Santini, L. Salvagno and P. Leoni, VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma, J. Clin. Oncol. 16 (1998), 2796-2802.
37. The International Non-Hodgkin's Lymphoma Prognostic Factors Project, A predictive model for aggressive non-Hodgkin's lymphoma, N. Engl. J. Med. 329 (1993), 987-994.
38. M. Tomobe, T. Shimazui, K. Ushida and H. Akaza, AgNOR count in resting cells is a new prognostic marker in invasive bladder tumour, Analyt. Cell. Pathol. 22 (2001), 193-199.
39. X. Xie, O.P. Clausen, P. de Angelis and M. Boysen, Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas, Br. J. Cancer 78 (1998), 100-105.
40. A.M. Zhang, K. Ohshima, K. Sato, M. Kanda, J. Suzumiya, K. Shimazaki, K. Kawasaki and M. Kikuchi, Prognostic clinicopathologic factors, including immunologic expression in diffuse large cell lymphomas, Pathol. Intern. 49 (1999), 1043-1052.